Seeing Is Believing
MRNS is currently covered by 9 analysts with an average price target of $11.66. This is a potential upside of $11.4 (4384.62%) from yesterday's end of day stock price of $0.26.
Marinus Pharmaceuticals's activity chart (see below) currently has 46 price targets and 72 ratings on display. The stock rating distribution of MRNS is 92.86% BUY and 7.14% HOLD.
Analysts average stock forecasts to be materialized ratio is 5.6% with an average time for these price targets to be met of 44.43 days.
Highest price target for MRNS is $13, Lowest price target is $3, average price target is $11.66.
Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 24-Sep-2024.
Currently out of the existing stock ratings of MRNS, 39 are a BUY (92.86%), 3 are a HOLD (7.14%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$13
$11.15 (602.70%)
$13
2 months 20 days ago
(24-Sep-2024)
0/7 (0%)
$11.1 (584.21%)
Hold
$6
$4.15 (224.32%)
$9
2 months 21 days ago
(23-Sep-2024)
1/6 (16.67%)
$4.31 (255.03%)
5
Buy
$13
4 months ago
(14-Aug-2024)
1/6 (16.67%)
$6.1 (88.41%)
309
Buy
$11
$9.15 (494.59%)
$11
4 months ago
(14-Aug-2024)
0/15 (0%)
$9.9 (900.00%)
Buy
$3
$1.15 (62.16%)
$21
7 months 29 days ago
(15-Apr-2024)
2/10 (20%)
$1.7 (130.77%)
247
What is MRNS (Marinus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on MRNS (Marinus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on MRNS (Marinus Pharmaceuticals)?
Which analyst is the currently most bullish on MRNS (Marinus Pharmaceuticals)?
Which analyst is the currently most reserved on MRNS (Marinus Pharmaceuticals)?